Colgate-Palmolive Company (VIE:COLG)
Austria · Delayed Price · Currency is EUR | Market Cap | 64.31B +9.4% |
| Revenue (ttm) | 18.42B +5.2% |
| Net Income | 1.78B -29.9% |
| EPS | 2.22 -28.8% |
| Shares Out | n/a |
| PE Ratio | 36.05 |
| Forward PE | 23.58 |
| Dividend | 1.80 (2.25%) |
| Ex-Dividend Date | Jul 20, 2026 |
| Volume | 125 |
| Open | 80.72 |
| Previous Close | 80.86 |
| Day's Range | 79.90 - 81.14 |
| 52-Week Range | 65.20 - 84.11 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 31, 2026 |
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells i... [Read more]
Financial Performance
In 2025, Colgate-Palmolive Company's revenue was $20.38 billion, an increase of 1.40% compared to the previous year's $20.10 billion. Earnings were $2.13 billion, a decrease of -26.20%.
Financial numbers in USD Financial StatementsNews
Colgate-Palmolive price target raised to $104 from $102 at RBC Capital
RBC Capital analyst Nik Modi raised the firm’s price target on Colgate-Palmolive (CL) to $104 from $102 and keeps an Outperform rating on the shares. The company reported a mixed…
Colgate-Palmolive price target raised to $101 from $99 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Colgate-Palmolive (CL) to $101 from $99 and keeps a Buy rating on the shares.
Colgate-Palmolive price target raised to $109 from $106 at UBS
UBS raised the firm’s price target on Colgate-Palmolive (CL) to $109 from $106 and keeps a Buy rating on the shares.
Colgate-Palmolive price target raised to $104 from $100 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Colgate-Palmolive (CL) to $104 from $100 and keeps an Overweight rating on the shares. The firm, which generally views the company’s Q2…
Colgate-Palmolive price target raised to $90 from $85 at TD Cowen
TD Cowen raised the firm’s price target on Colgate-Palmolive (CL) to $90 from $85 and keeps a Hold rating on the shares. The firm updated its model following inline results…
Colgate-Palmolive price target lowered to $103 from $104 at JPMorgan
JPMorgan lowered the firm’s price target on Colgate-Palmolive (CL) to $103 from $104 and keeps an Overweight rating on the shares. The firm says the company’s international growth continues to…
Colgate-Palmolive Company Earnings Call Transcript: Q2 2026
Strong top and bottom-line growth was achieved, led by emerging markets and innovation, with gross margin expanding and free cash flow up 18%. U.S. softness prompted targeted actions, while robust performance in Europe, Latin America, and Hill's pet business supported results.
Colgate-Palmolive Company Earnings release: Q2 2026
Colgate-Palmolive Company released its Q2 2026 earnings on July 31, 2026, summarizing the period's financial results.
Colgate-Palmolive Company Slides: Q2 2026
Colgate-Palmolive Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 31, 2026.
Colgate-Palmolive Company Quarterly report: Q2 2026
Colgate-Palmolive Company has published its Q2 2026 quarterly earnings report on July 31, 2026.
Colgate-Palmolive reaffirms annual sales forecast on weak North America demand
Colgate-Palmolive on Friday reaffirmed its annual sales forecast even after posting a quarterly rise as the toothpaste maker continues to grapple with muted demand in North America, sending its shar...
Colgate-Palmolive Sales Rise Despite Choppy Backdrop
Colgate-Palmolive recorded higher sales in the second quarter, despite a choppy consumer environment.
Colgate Announces 2nd Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL): Net sales increased 4.9%; Organic sales* increased 2.4%, including a 0.4% negative impact from lower private label pet food sales GAAP E...
Colgate-Palmolive price target raised to $87 from $80 at Barclays
Barclays analyst Lauren Lieberman raised the firm’s price target on Colgate-Palmolive (CL) to $87 from $80 and keeps an Equal Weight rating on the shares. The firm adjusted targets in…
Colgate-Palmolive Webcasts 2026 Second Quarter Earnings Conference Call July 31, 2026 – 8:30 a.m. ET
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2026 second quarter earnings conference call on Friday, July 31, 2026, at 8:30 a.m. ET. The call will ...
Colgate-Palmolive price target raised to $106 from $100 at UBS
UBS raised the firm’s price target on Colgate-Palmolive (CL) to $106 from $100 and keeps a Buy rating on the shares.
Colgate-Palmolive price target raised to $104 from $96 at JPMorgan
JPMorgan raised the firm’s price target on Colgate-Palmolive (CL) to $104 from $96 and keeps an Overweight rating on the shares. The firm adjusted targets in the beverage, household and…
Colgate-Palmolive price target raised to $110 from $105 at Citi
Citi raised the firm’s price target on Colgate-Palmolive (CL) to $110 from $105 and keeps a Buy rating on the shares. The firm adjusted targets in the beverages and household…
Colgate-Palmolive price target raised to $96 from $92 at Piper Sandler
Piper Sandler raised the firm’s price target on Colgate-Palmolive (CL) to $96 from $92 and keeps an Overweight rating on the shares. The firm notes top-line momentum outside the U.S.
Colgate-Palmolive price target raised to $95 from $92 at Wells Fargo
Wells Fargo analyst Chris Carey raised the firm’s price target on Colgate-Palmolive (CL) to $95 from $92 and keeps an Equal Weight rating on the shares. The firm sees this…
Freshpet pullback presents ‘attractive entry point,’ says Morgan Stanley
Morgan Stanley notes Freshpet (FRPT) shares are down 7% following news that Colgate’s (CL) Hill’s Pet Nutrition business will be launching Hill’s Science Diet Single Protein Dog Food Rolls in…
Colgate Declares Regular Quarterly Dividend
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.53 per common share, payable on August 14, 2026, to shareholders...
NYSE Content Update: PointFive Raises $60 Million to Redefine Efficiency
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 8, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NY...
Colgate-Palmolive Company Transcript: 23rd annual dbAccess Global Consumer Conference
Leadership highlighted transformation, innovation, and omnichannel strategies as central to future growth. Latin America remains a stronghold, while North America is targeted for turnaround through premiumization and innovation. AI and productivity initiatives are driving efficiency and global best practice sharing.
Colgate-Palmolive Launches Serving Smiles, a New Podcast Delivering Health Conversations Gen Z Actually Want to Have
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive, a global leader in health and hygiene, today announced the launch of Serving Smiles, a new video-first podcast designed to tackle health misinformation an...